Design, synthesis and biological evaluation of pyridine-phenylpiperazines: A novel series of potent and selective α1a-adrenergic receptor antagonist
- 31 August 2000
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 8 (9) , 2263-2275
- https://doi.org/10.1016/s0968-0896(00)00151-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The two-state model of receptor activationTrends in Pharmacological Sciences, 1995
- Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptorsJournal of Medicinal Chemistry, 1992
- Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell lineMolecular Endocrinology, 1992
- Molecular biology of dopamine receptorsTrends in Pharmacological Sciences, 1992
- Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lungInflammation Research, 1991
- The efficacy and safety of terazosin for the treatment of symptomatic BPHThe Prostate, 1991
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Cloning and expression of a rat D2 dopamine receptor cDNANature, 1988
- The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of ratsLife Sciences, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973